Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-27
1996-07-02
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483585, A61K 31415, C07D49506
Patent
active
055322638
ABSTRACT:
Novel 2H-[1]benzothiopyrano[4,3,2-cd]indazoles are disclosed as antitumor agents. Compositions containing the benzothiopyranoindazoles and methods of treating tumors and cancer in mammals with benzothiopyranoindazoles are also disclosed.
REFERENCES:
patent: 3505341 (1970-04-01), Elslager et al.
patent: 3963740 (1976-06-01), Elslager et al.
Blanz & French, J. Med. Chem., 1963, 6, 185-191.
Showalter et al, J. Med. Chem., 1988, 31, 1527-1538.
Bailly & Waring, Biochemistry, 1993, 32, 5985-5993.
Gordon & Chiang, The Journal of Pharmacology and Experimental Therapeutics, 1986, 236(1), 85-89.
Perni Robert B.
Wentland Mark P.
Alexander Michael D.
DuPont Paul E.
Ramsuer Robert W.
Sterling Winthrop Inc.
LandOfFree
Benzothiopyranoindazole antitumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiopyranoindazole antitumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiopyranoindazole antitumor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1506757